Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2

Kaufman, H. L., Aung, S., Morse, M., Wong, M., Lowder, J., Daniels, G., & McDermott, D. (2014). Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2. Journal for ImmunoTherapy of Cancer, 2(Suppl 3), P88. https://doi.org/10.1186/2051-1426-2-s3-p88